Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barbara B.
Contact Barbara B., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Reply
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. We appreciate Drs Anne and Oleti's interest in our article. First, to address the relevance and justifiability of our study, despite improved survival of preterm infants over the last several decades, there has not been a parallel decrease in the incidence of bronchopulmonary dysplasia (BPD).
Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Figure 1 Percent of study infants alive and extubated over the course of the study. Differences in rates of extubation were significant at weeks 1, 2, 3, and 4, P < .005.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barbara B.
Contact Barbara B., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack